Filing metadata

Accession number
0001104659-16-143746
Form type
Form 3
Filer
Aegerion Pharmaceuticals, Inc.
CIK
CIK 1338042
Filed
Sep 08, 2016
Reporting period
Aug 30, 2016
Description
Initial ownership

Explore SEC Filings Hub